Bladder

Edit

10-Minute Stretching Routine Aimed at Bladder Meridian May Reduce Leg Swelling, Proponents Say

Natural News 15 Jul 2026

A 10-minute stretching routine targeting the Bladder meridian, a concept from Traditional Chinese Medicine (TCM), may help alleviate leg swelling and ... .

Edit

Doctors said this 5-year-old boy's bladder had to be removed to beat cancer; a rare bladder-saving treatment changed his life

The Times of India 14 Jul 2026

This stopped the disease from spreading and made it small enough that our surgeons didn't have to remove the bladder.' 'Operating on a bladder this small is a real test of precision,' said Dr.

Edit

Urine biopsy offers a more accurate way to detect bladder, kidney and prostate cancers

Straits Times 12 Jul 2026

It provides patients with a less painful and invasive screening option ....

Edit

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer ...

Business Wire 11 Jul 2026

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE. PFE) and Astellas Pharma Inc. (TSE.

Edit

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin EligibilityPrescription MedicinesMedicines (Pfizer Inc)

Public Technologies 10 Jul 2026

Christopher Hoimes, DO, Director of the Bladder Cancer Program and Center for Cancer Immunotherapy at Duke Cancer Institute, and an EV-304 Principal Investigator ... About Muscle-Invasive Bladder Cancer ... iii World Bladder Cancer Patient Coalition.

Edit

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility (Pfizer Inc)

Public Technologies 10 Jul 2026

Christopher Hoimes, DO, Director of the Bladder Cancer Program and Center for Cancer Immunotherapy at Duke Cancer Institute, and an EV-304 Principal Investigator ... About Muscle-Invasive Bladder Cancer ... iii World Bladder Cancer Patient Coalition.

Edit

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) (Merck & Co Inc)

Public Technologies 10 Jul 2026

"Today's FDA approvals represent a meaningful development for patients who have muscle-invasive bladder cancer, as nearly half of these patients experience disease recurrence following bladder removal surgery," said Dr ... About bladder cancer.

Edit

Non-Muscle Invasive Bladder Cancer Market Size Expected to Witness Significant Growth by 2036, estimates DelveInsight

GetNews 09 Jul 2026

Emerging Non-Muscle Invasive Bladder Cancer therapies including CG0070 (CG Oncology), Sasanlimab (Pfizer), EG-70 (enGene), TAR-200 and TAR-210 (Johnson & Johnson), UGN-102 and UGN-103 (UroGen), Ruvidar (Theralase), and others are driving market size.

Edit

'I had my bladder removed after habit caused irreversible damage'

The Mirror 08 Jul 2026

Liv turned to a habit that caused irreversible damage to her body over two years ... .

Edit

Why that 'I'll go later' bathroom habit could be damaging your bladder, according to a urologist

The Times of India 08 Jul 2026

... actually worsen bladder irritation and increase the risk of infections.When lifestyle modifications are not sufficient, medications can help reduce bladder overactivity and improve bladder control.

Edit

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer (Urogen Pharma Ltd)

Public Technologies 08 Jul 2026

The IND clearance enables initiation of a planned Phase 1 clinical study in patients with non-muscle invasive bladder cancer (NMIBC) ... "Patients with non-muscle invasive bladder cancer continue to ...

Edit

Non Muscle Invasive Bladder Cancer Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering ...

GetNews 07 Jul 2026

DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Non Muscle Invasive Bladder Cancer pipeline landscape.

Edit

Ancient bladder stone surgery tool discovered at Bulgarian Roman city

Heritage Daily 04 Jul 2026

The instrument, known as a lithulkos, formed part of a specialised surgical kit used by ancient physicians to perform lithotomy—the delicate and often dangerous operation to remove bladder stones.

Edit

Rare Surgical Instrument Discovered at Ancient Greek City of Heraclea Sintica

Greek Reporter 04 Jul 2026

Archaeologists have uncovered an exceptionally rare ancient surgical instrument once used to remove bladder stones during excavations at the ancient Greek city of Heraclea Sintica (Greek ... Bladder stone ...

Edit

Overactive Bladder Pipeline 2026: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Astellas ...

GetNews 03 Jul 2026

“" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Overactive Bladder Market ... Some of the key takeaways from the Overactive Bladder Pipeline Report ..

Podcasts:

Latest News for: bladder

10-Minute Stretching Routine Aimed at Bladder Meridian May Reduce Leg Swelling, Proponents Say

Doctors said this 5-year-old boy's bladder had to be removed to beat cancer; a rare bladder-saving treatment changed his life

Urine biopsy offers a more accurate way to detect bladder, kidney and prostate cancers

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer ...

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin EligibilityPrescription MedicinesMedicines (Pfizer Inc)

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility (Pfizer Inc)

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) (Merck & Co Inc)

Non-Muscle Invasive Bladder Cancer Market Size Expected to Witness Significant Growth by 2036, estimates DelveInsight

'I had my bladder removed after habit caused irreversible damage'

Why that 'I'll go later' bathroom habit could be damaging your bladder, according to a urologist

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer (Urogen Pharma Ltd)

Non Muscle Invasive Bladder Cancer Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering ...

Ancient bladder stone surgery tool discovered at Bulgarian Roman city

Rare Surgical Instrument Discovered at Ancient Greek City of Heraclea Sintica

Overactive Bladder Pipeline 2026: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Astellas ...

Article Search

EXPLORE WN.com